In Control?: Ukrainian Opiate Substitution Treatment Patients Strive for a Voice in Their Treatment

REFERENCES

• Babayan, E. A., & Gonopolsky, M. H. (1981). Uchebnoe posobie po narkologii. New York: International Universities Press.
   Google Scholar
• Bruce, R. D., Dvoryak, S., Sylla, L., & Altice, F. A. (2007). HIV treatment access and scale-up for delivery for IDU in Ukraine with opiate substitution therapy with buprenorphine - programme description and policy implications. International Journal of Drug Policy, 18, 326–328.
   PubMed Web of Science ®Google Scholar
• Cohen, J. (2010). Law enforcement and drug treatment: A culture clash. Science, 329(5988), 169.
   PubMedGoogle Scholar
• Dumchev, K. V., Soldyshev, R., Qian, H.-Z., Zezyulin, O. O., Chandler, S. D., Slobodyanyuk, P., (2009). HIV and hepatitis C virus infections among hanka injection drug users in central Ukraine: A cross-sectional survey. Harm Reduction Journal, 6, 23.
   PubMedGoogle Scholar
• Dvoryak, S., & Skala, P. (2008). Substitution maintenance therapy in Ukraine: Can the community respond effectively to the challenges of HIV/AIDS. Kiev: International HIV/AIDS Alliance in Ukraine.
   Google Scholar
• Elovich, R., & Drucker, E. (2008). On drug treatment and social control: Russian narcology's great leap backwards. Harm Reduction Journal, 5, 23.
   Google Scholar
• Gowing, L., Farrell, M., Bornemann, R., Sullivan, L., & Ali, R. (2008). Substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database of Systematic Reviews, Issue 2, No. CD004145. doi: 10.1002 /14651858.CD004145.pub3.
   PubMedGoogle Scholar
• HIV/AIDS Alliance in Ukraine. (2009). Statistics: Number of new officially registered cases of HIV infection, AIDS, and lethal outcomes. Retrieved 4 September 2010, from http://www. aidsalliance.org.ua/cgi-bin/index.cgi?url=/ua/library/statistics/ index.htm [in Russian].
   Google Scholar
• Human Rights Watch. (2006). Risk and rhetoric: Human rights abuses impeding Ukraine's fight against HIV/AIDS. New York: Human Rights Watch.
   Google Scholar
• International Dual Loyalty Working Group. (2002). Dual loyalty and human rights in health professional practice: Proposed guidelines and institutional mechanisms. Cambridge, MA: Physicians for Human Rights and School of Public Health and Primary Health Care, Health Sciences Faculty, University of Cape Town.
   Google Scholar
• Kruglov, Y. V., Kobyshcha, Y. V., Salyuk, T., Varetska, O., Shakarishvili, A., & Saldanha, V. P. (2008). The most severe HIV epidemic in Europe: Ukraine's national HIV prevalence estimates for 2007. Sexually Transmitted Infections, 84(Suppl. 1), i37–i41.
   PubMedGoogle Scholar
• Mattick, R. P., Kimber, J., Breen, C., & Davoli, M. (2008). Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews, Issue 2. No. CD002207. doi: 10.1002/14651858.
   PubMed Web of Science ®Google Scholar
• Ministry of Health. (1978). Duration of minimimally required terms of treatment of patients that abuse narcotics, and toxic substances (Order No. 388 of the Ministry of Health of the USSR of 19 April 1978). Moscow: Author.
   Google Scholar
• Ministry of Health. (1988). On the periods of follow-up observation of persons affected by the diseases alcoholism, drug dependence, dependence on toxic substances (Order No. 704 of the Ministry of Health of the USSR of 12 September 1988). Moscow: Author [in Russian].
   Google Scholar
• Roux, P., Carrieri, M. P., Cohen, J., Ravaux, I., Poizot Martin, I., Dellamonica, P., (2009). Retention in opioid substitution treatment: A major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment. Clinical Infectious Diseases, 49(9), 1433–1440.
   PubMed Web of Science ®Google Scholar
• Schaub, M., Chtenguelov, V., Subata, E., Weller, G., & Uchtenhagen, A. (2010). Feasibility of buprenorphine and methadone maintenance programmes among users of home made opioids in Ukraine. International Journal of Drug Policy, 21(3), 229–233.
   PubMedGoogle Scholar
• Shields, A. (2009). The effects of drug user registration laws on people's rights and health: Findings from Russia, Georgia, and Ukraine. New York: Open Society Institute.
   Google Scholar
• Thorne, C., Semenenko, I., Pilipenko, T., & Malyuta, R. (2009). The Ukraine European Collaborative Study Group progress in prevention of mother-to-child transmission of HIV infection in Ukraine: Results from a birth cohort study. BMC Infectious Diseases, 9, 40.
   PubMed Web of Science ®Google Scholar
• Tolopilo, A., & Vlasenko, L. (2008). Drug user registration: Practices, consequences, and the future [in Russian]. Kiev: Ukrainian Institute of Public Health Policy.
   Google Scholar
• Uchtenhagen, A., & Shaub, M. (2010). Final monitoring and evaluation report on opioid substitution treatment in Ukraine. Zurich: Research Institute for Public Health and Addiction and Zurich University.
   Google Scholar
• Ukrainian Institute on Public Health Policy. (2010). Data on the number of patients in OST programs as of August 15, 2010. Retrieved 4 September 2010, from http://www.uiphp.org.ua/ua/ resource/zvedeni-danni/ [in Russian].
   Google Scholar
• Wolfe, D. (2007). Paradoxes in antiretroviral treatment for injecting drug users: Access, adherence and structural barriers in Asia and the former Soviet Union. International Journal of Drug Policy, 18(4), 246–254.
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO), United Nations Office on Drugs and Crime (UNODC), and United Nations Program on HIV/AIDS (UNAIDS). (2009). Technical guide for countries to set targets for universal access to HIV prevention, treatment, and care for injecting drug users. Geneva: WHO.
   Google Scholar